| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | CSO and CDO | Ordinary Shares | 50,707 | $123,725 | $2.44 | 20 Feb 2026 | Direct |
| Silexion Therapeutics Corp | CSO and CDO | Stock Option (right to buy Ordinary Shares) | 478 | $1,166 | $2.44 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | 20 Feb 2026 | 1 | $0 | 4 | CSO and CDO | 23 Feb 2026, 16:18 |
| SLXN | Biomotion Sciences | 15 Aug 2024 | 0 | $0 | 3 | CSO and DO | 15 Aug 2024, 19:49 |